Contrasting treatment-specific survival using double-robust estimators.
about
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation.A log rank type test in observational survival studies with stratified sampling.Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and OpportunitiesLandmark estimation of survival and treatment effects in observational studies.Doubly robust estimation of attributable fractions in survival analysis.
P2860
Contrasting treatment-specific survival using double-robust estimators.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Contrasting treatment-specific survival using double-robust estimators.
@ast
Contrasting treatment-specific survival using double-robust estimators.
@en
Contrasting treatment-specific survival using double-robust estimators.
@nl
type
label
Contrasting treatment-specific survival using double-robust estimators.
@ast
Contrasting treatment-specific survival using double-robust estimators.
@en
Contrasting treatment-specific survival using double-robust estimators.
@nl
prefLabel
Contrasting treatment-specific survival using double-robust estimators.
@ast
Contrasting treatment-specific survival using double-robust estimators.
@en
Contrasting treatment-specific survival using double-robust estimators.
@nl
P2860
P356
P1476
Contrasting treatment-specific survival using double-robust estimators.
@en
P2093
Douglas E Schaubel
P2860
P304
P356
10.1002/SIM.5511
P407
P577
2012-07-16T00:00:00Z